The purpose of the Biostatistics and Data Management Core for this program project is to provide acomprehensive, multi-disciplinary resource for design of clinical and basic science experiments,development of appropriate and innovative statistical methodology, statistical analysis, and summarizing theresults. The Biostatistics and Data Management Core has the following overall goals: to provide statisticalconsulting and collaboration on the design, conduct, analysis and interpretation of all program projectresearch studies and cores, and to provide, manage and maintain a high-quality research database thatsupports the research projects and cores while preserving the confidentiality of all subject data.
The specificaims are: (1) Coordinate and manage statistical activities in the program project to ensure that investigatorshave ready access to statistical consultation and support. (2) Provide statistical expertise in the design ofexperiments and studies, including research proposal development, sample size determination,randomization procedures, and plans for interim reviews and final analysis. (3) Assist with the writing ofstatistical components of manuscripts. (4) Review, in conjunction with the Clinical Translational ReviewCommittee, the integrity and statistical soundness of all studies involving human subjects. (5) Providestatistical analysis for all projects using appropriate statistical and computing methodologies, assist in theinterpretation and presentation of results. (6) Interact and collaborate with the Clinical Trials andTranslational Research Office in the development of protocols and the monitoring and reporting of clinicaldata. (7) Maintain a computing facility with up-to-date software for statistical analysis to support programproject investigators. (8) Conduct biostatistical methodology research on practical problems arising in cancerstudies. (9) Provide computer-based tools that facilitate the storage and retrieval of the data generated in theproposed research, thereby creating and maintaining a centralized relational database that provides accessto common resources and information. (10) Ensure the accuracy of the data maintained in the database bysoftware based data consistency and quality control systems. (11) Organize and maintain the database tomaximize accuracy and accessibility; while maintaining strict confidentiality. (12) Provide detaileddescriptions of the available populations and resources for current and future investigators. (13) Providehigh-quality data entry services.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA116676-01A1
Application #
7109521
Study Section
Subcommittee G - Education (NCI)
Project Start
2006-01-01
Project End
2010-12-31
Budget Start
2006-01-01
Budget End
2007-05-31
Support Year
1
Fiscal Year
2006
Total Cost
$82,097
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Liu, Fakeng; Liu, Yuan; Liu, Xiuju et al. (2018) Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer. Lung Cancer 123:36-43
Xiong, Fei; Jiang, Miao; Chen, Meijuan et al. (2017) Study on Inhibitory Effect of MaiMenDong Decoction and WeiJing Decoction Combination with Cisplatin on NCI-A549 Xenograft in Nude Mice and Its Mechanism. J Cancer 8:2449-2455
Gilbert-Ross, Melissa; Konen, Jessica; Koo, Junghui et al. (2017) Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma. JCI Insight 2:e90487
Li, Zenggang; Ivanov, Andrei A; Su, Rina et al. (2017) The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun 8:14356
Zhang, Jun; Nannapaneni, Sreenivas; Wang, Dongsheng et al. (2017) Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status. Oncotarget 8:59008-59022
Sun, Linlin; Liu, Xiuju; Fu, Haian et al. (2016) 2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells. PLoS One 11:e0168793
Jin, Rui; Zhou, Wei (2016) TIF-IA: An oncogenic target of pre-ribosomal RNA synthesis. Biochim Biophys Acta 1866:189-196
Liu, Fakeng; Jin, Rui; Liu, Xiuju et al. (2016) LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions. Oncotarget 7:2519-31
Feng, Xiuyan; Li, Zenggang; Du, Yuhong et al. (2015) Downregulation of urea transporter UT-A1 activity by 14-3-3 protein. Am J Physiol Renal Physiol 309:F71-8
Owonikoko, Taofeek K; Ramalingam, Suresh S; Miller, Daniel L et al. (2015) A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer. Clin Cancer Res 21:1859-68

Showing the most recent 10 out of 105 publications